Page last updated: 2024-11-11

martynoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

martynoside: isolated from Verbena bipinnatifida Nutt; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
VerbenagenusA plant genus of the family VERBENACEAE. Members contain verbenachalcone (dimeric dihydrochalcone), iridoids, and phenylethanoids.[MeSH]VerbenaceaeA plant family of the order Lamiales, subclass Asteridae, class Magnoliopsida. The leaves are opposite or whorled. The flowers are aggregated in spikes, clusters, or racemes.[MeSH]
Verbena bipinnatifidaspecies[no description available]VerbenaceaeA plant family of the order Lamiales, subclass Asteridae, class Magnoliopsida. The leaves are opposite or whorled. The flowers are aggregated in spikes, clusters, or racemes.[MeSH]
Verbena bipinnatifidaspecies[no description available]VerbenaceaeA plant family of the order Lamiales, subclass Asteridae, class Magnoliopsida. The leaves are opposite or whorled. The flowers are aggregated in spikes, clusters, or racemes.[MeSH]

Cross-References

ID SourceID
PubMed CID5319292
CHEMBL ID503531
SCHEMBL ID2158040
MeSH IDM0365675

Synonyms (15)

Synonym
martynoside
67884-12-2
nsc729643
nsc-729643
CHEMBL503531
[(2r,3r,4r,5r,6r)-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-2-(hydroxymethyl)-4-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
SCHEMBL2158040
DTXSID70415748
AKOS032948458
MS-30970
XM178229
nsc 729643
CS-0023884
HY-N3316
E87106

Research Excerpts

Overview

Martynoside (MAR) is a bioactive glycoside of Rehmannia glutinosa, a traditional Chinese herb frequently prescribed for treating chemotherapy-induced pancytopenia.

ExcerptReferenceRelevance
"Martynoside (MAR) is a bioactive glycoside of Rehmannia glutinosa, a traditional Chinese herb frequently prescribed for treating chemotherapy-induced pancytopenia. "( Ex vivo and in vivo chemoprotective activity and potential mechanism of Martynoside against 5-fluorouracil-induced bone marrow cytotoxicity.
Chen, D; Chen, L; Du, Y; Hong, M; Hong, Z; Qian, J; Sun, R; Tang, K; Yao, Y; Ye, T, 2021
)
2.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID402101Cytotoxicity against human Raji cells assessed as cell viability at 500 molar ratio after 48 hrs1998Journal of natural products, Sep, Volume: 61, Issue:9
New glycosides from ajuga decumbens
AID1171851Antibacterial activity against Staphylococcus aureus assessed as growth inhibition after 24 hrs by broth microdilution assay2014Journal of natural products, Dec-26, Volume: 77, Issue:12
Indole alkaloid glycosides from the aerial parts of Strobilanthes cusia.
AID402096Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio after 48 hrs1998Journal of natural products, Sep, Volume: 61, Issue:9
New glycosides from ajuga decumbens
AID402097Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 10 molar ratio after 48 hrs relative to TPA by indirect immunofluorescence technique1998Journal of natural products, Sep, Volume: 61, Issue:9
New glycosides from ajuga decumbens
AID402102Cytotoxicity against human Raji cells assessed as cell viability at 100 molar ratio after 48 hrs1998Journal of natural products, Sep, Volume: 61, Issue:9
New glycosides from ajuga decumbens
AID425005DPPH radical scavenging activity assessed as ratio of antioxidant concentration to drug level causing 50% decrease in DPPH level at steady state at 100 ug by TLC autographic assay2009Journal of natural products, May-22, Volume: 72, Issue:5
Antioxidant phenylethanoid glycosides and a neolignan from Jacaranda caucana.
AID425006Antioxidant activity assessed as protection against peroxyl radical-induced alkaline phosphatase activity loss by microplate assay2009Journal of natural products, May-22, Volume: 72, Issue:5
Antioxidant phenylethanoid glycosides and a neolignan from Jacaranda caucana.
AID402100Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 1000 molar ratio after 48 hrs relative to TPA by indirect immunofluorescence technique1998Journal of natural products, Sep, Volume: 61, Issue:9
New glycosides from ajuga decumbens
AID402103Cytotoxicity against human Raji cells assessed as cell viability at 10 molar ratio after 48 hrs1998Journal of natural products, Sep, Volume: 61, Issue:9
New glycosides from ajuga decumbens
AID294168Inhibition of diphenolase activity of mushroom tyrosinase at 0.052 mM2007Bioorganic & medicinal chemistry, Apr-01, Volume: 15, Issue:7
Identification of tyrosinase inhibitors from Marrubium velutinum and Marrubium cylleneum.
AID402098Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 100 molar ratio after 48 hrs relative to TPA by indirect immunofluorescence technique1998Journal of natural products, Sep, Volume: 61, Issue:9
New glycosides from ajuga decumbens
AID402099Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 500 molar ratio after 48 hrs relative to TPA by indirect immunofluorescence technique1998Journal of natural products, Sep, Volume: 61, Issue:9
New glycosides from ajuga decumbens
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (7.14)18.2507
2000's7 (50.00)29.6817
2010's4 (28.57)24.3611
2020's2 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.95

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.95 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index5.42 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.95)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]